comparison of efficacy of two treatment regimen,cefazolin alone with cefazolin plus metronidazol in the prevention of surgical site infections after hysterectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200128046289N1

Enrollment

400

Registered

2020-02-22

Start date

2020-02-04

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Site Infection after Hysterectomy. Infection following a procedure

Interventions

Intervention 1: Patients who are candidate for hysterectomy receiving Cefazolin 2gr IV one hour before surgery alone as control group. Intervention 2: Patients who are candidate for hysterectomy recei

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women who are candidates for hysterectomy

Exclusion criteria

Exclusion criteria: Sensitivities to cefazolin Sensitivities to metronidazole sensitivities to penicillins

Design outcomes

Primary

Measure	Time frame
Postoperative infection. Timepoint: Twelve months. Method of measurement: Based on ICD-10 Code criteria description.	—

Secondary

Measure	Time frame
Prevention of infection after hysterectomy. Timepoint: Thirty days after the hysterectomy. Method of measurement: Clinical signs of wound infection (redness, swelling, warmth, discharge).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasomeh Bayani

Babol University of Medical Sciences

m_baiany@yahoo.com009832238284

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026